CTOs on the Move

Sernova

www.sernova.com

 
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sernova.com
  • 700 Collip Circle Suite 114
    London, ON CAN N6G 4X8
  • Phone: 877.299.4603

Executives

Name Title Contact Details
Philip Toleikis
 Chief Technology Officer Profile

Similar Companies

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

Carepartners Health Services

Carepartners Health Services is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Coding Solutions

Advanced Coding Solutions is a White House, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kiwi-Tek

Kiwi-Tek is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BeniComp Advantage

BeniComp Advantage is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.